Category: Q2Syndicate content

Nobel Biocare's Q2 profits double as it fields buyout interest

August 21, 2014 by Brad Perriello

Nobel Biocare doubles its 2nd-quarter profits as it reportedly fields interest – and at least 1 offer worth $2.3 billion – from potential acquirers.

Nobel Biocare's Q2 profits double as it fields buyout interest

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

ConvaTec said to explore 2015 sale

August 19, 2014 by Brad Perriello

ConvaTec is reportedly weighing a sale of the private-equity-owned medical device company next year, even as interest in a Medtronic-like inversion deal mounts from C.R. Bard, CareFusion and 3M.

ConvaTec said to explore 2015 sale

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic's Q1 earnings beat The Street on modest sales bump

August 19, 2014 by Brad Perriello

Medtronic's fiscal 1st-quarter earnings beat Wall Street's forecast by a penny on a modest single-digit sales increase.

Medtronic's Q1 earnings beat The Street on modest sales bump

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes: DexCom's revenues jump 64% in Q2

August 11, 2014 by Arezu Sarvestani

Diabetes devices maker DexCom gets some Wall Street love after gaining major momentum in the 2nd quarter.

Diabetes: DexCom's revenues jump 64% in Q2

Diabetes devices maker  (NSDQ:DXCM) got a lot of love from Wall Street after issuing its latest quarterly report, with DXCM shares gaining 14.5% since last week.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

EnteroMedics' losses widen as it chases FDA approval

August 8, 2014 by Arezu Sarvestani

Weight-loss implant EnteroMedics falls short of analysts' expectations during its 2nd quarter as the company continues to pursue FDA approval of its flagship Maestro nerve-stimulation device.

EnteroMedics losses widen as it chases FDA approval

Minnesota-based EnteroMedics (NSDQ:ETRM) gained modestly this week after announcing its latest financial report, even though the company missed the mark by a penny.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Strong Q4, $750M buyback give CareFusion a boost

August 8, 2014 by Arezu Sarvestani

CareFusion gains a couple points after posting a Street-beating 4th quarter and announcing a $750 million share repurchase program.

Strong Q2, $750M buyback give CareFusion a boost

CareFusion (NYSE:CFN) posted a stellar 4th-quarter, posting double-digit growth in revenues and earnings and beating Wall Street's estimates.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Masimo sinks as Q2 misses the mark

August 8, 2014 by Arezu Sarvestani

Masimo's stock drops 13% as its latest quarter misses analysts' estimates and full-year guidance narrows down.

Masimo sinks as Q2 misses the mark

California device maker Masimo (NSDQ:MASI) got no Wall Street love this week after announcing results for its most recent quarter.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp